- Home >
- Clinicals Trials >
- SCANDARE (IC 2016-03)
SCANDARE (IC 2016-03)
Prospective biobanking study in ovarian, breast and head and neck cancer patients aiming at better understand the link between the molecular alterations of the tumor itself, its microenvironment and immune response.
- Open at Paris since : 25/01/2017
- Open at Saint-Cloud since : 19/12/2016
- Target : Adult
- Phase : Clinical trial
Trial description
This study involves patients who will get surgery for head and neck cancer, ovarian cancer or triple-negative breast cancer. This study does not involve drugs but collects tumor and blood samples in order to further study the cross-talks between cancer genetics and its microenvironement.
Url of the trial